Alzchem Group Ag · XETR:ACT
Alzchem — Q2 2021 Earnings Presentation
35 slides from Alzchem's earnings presentation, Aug 5, 2021
Slide 1: AlzChem Group AG Q2 2021
AlzChem Group AG Andreas Niedermaier, CEO Dr. Georg Weichselbaumer, CSO August 5, 2021 2021 Q2
Slide 2: Disclaimer
DISCLAIMER Cautionary note regarding forward-looking statements This presentation contains forward-looking statements about the business, financial condition and earnings performance of the AlzChem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 3: Agenda
AGENDA Analyst Presentation Q2/2021 EXECUTIVE SUMMARY BUSINESS AND FINANCIAL DETAILS BACK-UP ALZCHEM GROUP AG – Q2/2021 FINANCIAL REPORT ANALYST PRESENTATION 3
Slide 4: Highlights
HIGHLIGHTS Record half year of AlzChem Group AG ! European supply chain is Positive business Raw material becoming more and more development leads to markets, energy important for customers, an increase in financial purchase and successful commissioning forecast for the fiscal logistics are still Ni
Slide 5: Creatine Monohydrate for Functional Food
CREATINE MONOHYDRATE FOR FUNCTIONAL FOOD Creapure® - Vitality, Energy and Well-Being Creapure® is an Excellent Ingredient for Enriching Foods and Completing the Diet of Vegans and Vegetarians Creatine: Energy throughout the body • Creatine is crucial for the energy metabolism of the body. • increase
Slide 6: Decision taken to expand capacity for Creatine and precursors
Decision taken to expand capacity for Creatine and precursors SPECIALTY CHEMICALS The additional investment will create profitable growth for the segment Regional market penetration ~11 m€ Regional market expansion INVESTMENT Product shortage on the market New sales products added New Creapure appli
Slide 7: Eminex
EMINEX® Climate protection the easy way - Calcium Cyanamide changes agriculture Eminex® suppresses methane and CO2 emissions during manure slurry storage and improves your environmental footprint. EMINEX > 50% of methane emissions in Germany originate from agriculture. Immission Workers Nitrogen Phy
Slide 8: Financial Overview Q2/2021
FINANCIAL OVERVIEW Q2/2021 Key figures Q2 Q2 2020 2021 AlzChem Group yoy % yoy % 2020 2021 1-6 1-6 SALES (in M€) 102.5 111.0 +8.3% 197.3 215.3 +9.2% EBITDA (in M€) 16.8 19.0 +12.9% 29.1 35.7 +22.6% EBITDA margin (in %) 16.4% 17.1% +0.7 pp 14.8% 16.6% +1.8 pp Earnings per Share (in €) 0.66 0.90 +36.7
Slide 9: Agenda
AGENDA Analyst Presentation Q2/2021 EXECUTIVE SUMMARY BUSINESS AND FINANCIAL DETAILS BACK-UP 9
Slide 10: Basics & Intermediates
NUTRITION & AGRO BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of specia
Slide 11: Basics & Intermediates Segment
BASICS & INTERMEDIATES SEGMENT Strong sales and powerful EBITDA development SALES +18.1% SALES EBITDA SALES ANALYSIS 45,2 DELTA DELTA 41,7 39,8 41,1 37,8 36,0 38,3 Q2 01 - 06 34,4 32,3 +16.1% Volume 14.1% 14.3% 86,2 Price 5.1% 2.8% 74,3 Currency -1.2% -0.9% Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2019 2019 2019
Slide 12: Specialty Chemicals
NUTRITION SPECIALTY &CHEMICALS AGRO The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals. 12
Slide 13: Specialty Chemicals Segment
SPECIALTY CHEMICALS SEGMENT Positive development of sales and EBITDA SALES +2.6% SALES EBITDA SALES ANALYSIS 57,9 56,8 59,3 DELTA DELTA 51,7 51,0 52,2 54,4 47,3 +5.5% Q2 01 - 06 43,0 Volume 4.6% 8.2% 116,1 110,1 Price 0.1% -0.4% Currency -2.1% -2.3% Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 +16.8% 2019 2019 2019 2
Slide 14: Other & Holding
NUTRITION & AGRO OTHER & HOLDING The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers. 14
Slide 15: Other & Holding Segment
OTHER & HOLDING SEGMENT Service sales on previous year level SALES SALES EBITDA SALES ANALYSIS +1.6% DELTA DELTA 6,6 6,8 6,7 6,5 6,4 6,4 6,5 6,5 6,1 Q2 01 - 06 Volume -0.8% -2.0% Price 2.4% 2.3% Currency 0.0% 0.0% +0.4% Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2019 2019 2019 2020 2020 2020 2020 2021 2021 12,9 13,
Slide 16: Balance Sheet
BALANCE SHEET Equity ratio increased ASSETS LIABILITIES 365.6 365.6 354.3 354.3 68,7 81,8 Equity 195,5 Other non-current assets 194,6 84,0 77,3 Other non-current liabilities 25,1 Deferred taxes for pension provision 27,2 135,5 Pension provision 141,8 67,4 Inventories 67,4 33,1 50,1 Trade receivables
Slide 17: Cashflow
CASHFLOW Very strong net cashflow in 1-6/2021 Cashflow from ongoing Cashflow from Cashflow from Net increase / decrease operations (Net cashflow) investing activity financing activity in cash and cash equivalents +25,7 -16.4 +11,7 -9.6 -1.0 +1,0 -15.7 -6,4 1–6 1–6 1–6 1–6 1–6 1–6 1–6 1–6 2020 2021 2
Slide 18: Implementing Operating Targets
IMPLEMENTING OPERATING TARGETS Focus on key growth drivers, sustainability and pandemic management SUSTAINABILITY REALIZATION OF THE NEXT NITRALZ® CAPACITY EXPANSIONS STABLE FURTHER DEVELOPMENT OF PHARMACEUTICAL RAW MATERIALS EXPANSION OF NEW PRODUCTION CAPACITIES (CREAPURE ®) ESTABLISH SALES OF LIV
Slide 19: Outlook 2021
OUTLOOK 2021 Significant upward adjustment of original forecast SALES EBITDA COMMENTS Slightly Rising to • Assumptions: continuing recovery of the rising to strong rising rising economy, no negative impacts from the raw 415.0 materials supply and no greater restriction due to 400.0 CORONA pandemic/l
Slide 20: Financial Calendar
FINANCIAL CALENDAR Upcoming dates 2021 AUG 5 Half-Year Financial Report 2021 2021 SEP 6 – 7 Fall Conference Berenberg and Goldman Sachs 2021 SEP 21 Tenth German Corporate Conference 2021 SEP 23 Baader Investment Conference 2021 NOV 11 Quarterly Statement 3rd Quarter 2021 2021 NOV 22 – 24 Deutsches E
Slide 21: Sales
M€ M€ M€ 1,631 ~215 ~36 ~26 EMPLOYEES SALES EBITDA OPERATING (PY 1,631) (PY ~197) (PY ~29) CASHFLOW (PY ~12) Other and Holding ALZCHEM 6,0% PRODUCTS ARE SOLD WORLDWIDE Basics 40.1% & Intermediates SALES YTD 2021/06 INNOVATION SINCE 53.9% Specialty 1908 Chemicals All financial indicators relating to
Slide 22: Thank You
CONTACT THANK YOU VIELEN DANK FÜR Investor Relations T +49 8621 86-2888 IHRE YOUR FOR AUFMERKSAMKEIT! ATTENTION! F +49 8621 86-502888 ir@alzchem.com WWW.ALZCHEM.COM
Slide 23: Agenda
AGENDA Analyst Presentation Q2/2021 EXECUTIVE SUMMARY BUSINESS AND FINANCIAL DETAILS BACK-UP ALZCHEM GROUP AG – Q2/2021 FINANCIAL REPORT ANALYST PRESENTATION 23
Slide 24: Balance Sheet
BALANCE SHEET AlzChem Group ALZCHEM GROUP (IN T€) 31.12.2020 30.06.2021 Deviation ALZCHEM GROUP (IN T€) 31.12.2020 30.06.2021 Deviation Share capital 101,763 101,763 Intangible assets 1,810 1,767 -44 -2.4% RETAINED EARNINGS (+) / LOSS (-) 81,356 90,593 9,237 11.4% Tangible assets 175,062 176,680 1,6
Slide 25: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) AlzChem Group (M€) -4.43% 141.8 +0.5 +0.4 -0.7 -6.4 135.5 -25.1 110.4 PENSION SERVICE NET INTEREST PENSION PENSION PENSION DEFERRED PENSION IN FINANCIAL PROVISION COSTS COSTS PAYMENTS REMEASURE- PROVISION TAX ASSETS LIABILITY STATEMENT 31.12.2020 MENTS 30.06.2021 30.06.2021
Slide 26: Income Statement
INCOME STATEMENT AlzChem Group 01.01.2020 - 01.04.2020 - 01.07.2020 - 01.10.2020 - 01.01.2021 - 01.04.2021 - 01.07.2021 - 01.10.2021 - 31.03.2020 30.06.2020 30.09.2020 31.12.2020 31.03.2021 30.06.2021 30.09.2021 31.12.2021 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 YTD YTD Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 ALZCHEM GROUP (IN T€)
Slide 27: Income Statement
INCOME STATEMENT AlzChem Group Q2 Q2 YTD YTD ALZCHEM GROUP (IN T€) Deviation (QoQ) Deviation (YoY) 2020 2021 Jun.2020 Jun.2021 Revenue 102,511 111,000 8,488 8.3% 197,251 215,321 18,070 9.2% Increase (+) / Decrease (-) in inventories of finished goods and work in progress -3,162 -1,621 1,541 -48.7% -
Slide 28: Cash Flow
CASH FLOW AlzChem Group Q2 Q2 1-6 1-6 CASHFLOW (IN M€) 2020 2021 2020 2021 Consolidated earnings before taxes 9,721 12,924 16,207 23,963 Depreciation on fixed and intangible assets 5,742 5,900 11,324 11,671 Decrease in pension provisions -257 -329 -635 -749 Loss (+) / Profit (-) from the sale of non
Slide 29: Segment Overview by Quarter
SEGMENT OVERVIEW BY QUARTER AlzChem Group 2019 2020 2021 YTD Q2 2021 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Deviation PY (Q2) PY Actual Deviation PY (YOY) SALES T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ T€ % T€ T€ T€ % Basics & Intermediates 35,465 37,844 41,693 34,405 36,012 38,266 32,320 39,837 41,070 45,1
Slide 30: Executive Team
EXECUTIVE TEAM AlzChem Group AG ANDREAS NIEDERMAIER, CEO WITH ALZCHEM SINCE 1999 AREAS OF RESPONSIBILITY Company Strategy, Finance & Controlling, Investor Relations & Communication, IT, Risk Management, HR, Supply Chain Management, Legal/Patents & Trademarks KLAUS ENGLMAIER, COO DR. GEORG WITH ALZCH
Slide 31: AlzChem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies SUNDSVALL (SE) SALES COMPANY PRODUCTION SITE TROSTBERG (GER) SCHALCHEN (GER) HART a. d. ALZ (GER) WALDKRAIBURG (GER) ATLANTA (USA) Production facilities in Germany (4) and Sweden (1) and HQ in Trostberg (GER) SHANGHAI (CN) 31
Slide 32: Fully Integrated Business Model (Verbund System)
Fully Integrated Business Model (“Verbund” System) Ability to adapt production to satisfy changing end market needs Segment Specialty Chemicals BENEFITS OF “VERBUND” • Full control of product quality and specifications • Lower costs • Higher financial predictability • Certainty of supply • Well posi
Slide 33: Specialty Chemicals: Our Products and Markets
OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION END-MARKETS A feed additive for broilers and pigs Feed additive Premium brand for creatine monohydrate as a food supplement in sports nutrition Food supplements Dietary supplement with pu
Slide 34: Intermediates: Our Products and Markets
OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION END-MARKETS Calcium carbide-based mixtures for hot metal desulphurization Steel industry INTERMEDIATES Fuel for airbags, key production of the intermediate product Automotive BASICS & Pha
Slide 35: Key Share Data
KEY SHARE DATA Share Details as of August 3, 2021 10,176,335 SHAREHOLDER STRUCTURE SHARES OUTSTANDING including 40,581 shares held by AlzChem Group AG LAST CLOSING PRICE EUR 25.00 LIVIA Corporate Development SE 29.59% MARKET CAPITALIZATION EUR 254.4 m Free float 42.93% including M&G plc 7.10% TICKER